(Q37427396)

20 August 2017

1 reference

title

Anti-drug vaccines to treat substance abuse (English)

1 reference

20 August 2017

0 references

2

David C Jackson

1 reference

20 August 2017

Berma M Kinsey

1

1 reference

PubMed ID

19333250

20 August 2017

Frank M Orson

series ordinal

3

1 reference

20 August 2017

31 March 2009

1 reference

Immunology & Cell Biology

20 August 2017

1 reference

20 August 2017

87

1 reference

20 August 2017

4

1 reference

20 August 2017

309-314

1 reference

The serotonin 2A receptor gene in alcohol dependence and tobacco smoking

20 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Influence of active and passive immunity on the disposition of dihydromorphine-H3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Efficacy of a therapeutic cocaine vaccine in rodent models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Treating cocaine addiction with viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Active immunization against nicotine suppresses nicotine-induced dopamine release in the rat nucleus accumbens shell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Effects of a nicotine conjugate vaccine on the acquisition and maintenance of nicotine self-administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

A new strategy for improved nicotine vaccines using conformationally constrained haptens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Immunization to nicotine with a peptide-based vaccine composed of a conformationally biased agonist of C5a as a molecular adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Correlation between pharmacological effects and plasma cocaine concentrations after smoked administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Kinetics in interactions between antibodies and haptens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Symptoms of tobacco dependence after brief intermittent use: the Development and Assessment of Nicotine Dependence in Youth-2 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Disrupting nicotine reinforcement: from cigarette to brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Current status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Investigations using immunization to attenuate the psychoactive effects of nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Enhanced immunogenicity of a bivalent nicotine vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Addictive drugs and their relationship with infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

New treatments for cocaine dependence: a focused review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

New developments in the pharmacotherapy of cocaine abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Novel approaches to the treatment of cocaine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Probes for the cocaine receptor. Potentially irreversible ligands for the dopamine transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Development of monoclonal antibodies directed against cocaine and cocaethylene: potential new tools for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Active immunization with cocaine-protein conjugate attenuates cocaine effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Covalent modification of proteins by cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

A meta-analytic review of psychosocial interventions for substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

A novel bivalent morphine/heroin vaccine that prevents relapse to heroin addiction in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Development of murine monoclonal antibodies to methamphetamine and methamphetamine analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Engineering of recombinant antibody fragments to methamphetamine by anchored periplasmic expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Using hapten design to discover therapeutic monoclonal antibodies for treating methamphetamine abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Development and preclinical testing of a high-affinity single-chain antibody against (+)-methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

The search for medications to treat stimulant dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Development of immunopharmacotherapy against drugs of abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

Intranasal Vaccination with a Lipopeptide Containing a Conformationally Constrained Conserved Minimal Peptide, a Universal T Cell Epitope, and a Self‐Adjuvanting Lipid Protects Mice from Group A Streptococcus Challenge and Reduces Throat Colonizati

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

D2 dopamine receptor gene haplotypes and their influence on alcohol and tobacco consumption magnitude in alcohol-dependent individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

7 January 2021

Preclinical development of a vaccine 'against smoking'.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

7 January 2021

Structural requirements for recognition of vasopressin by antibody; thermodynamic and kinetic characteristics of the interaction

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

7 January 2021

VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

7 January 2021

Anti-nicotine abuse vaccines in the pipeline: an update

1 reference

https://api.crossref.org/works/10.1038%2FICB.2009.17

7 January 2021

Identifiers

DOI

10.1038/ICB.2009.17

1 reference

20 August 2017

1 reference

PubMed ID

19333250